<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24340831</identifier>
<setSpec>1134-7198</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Lacadena, Juan-Ramón</dc:author>
<dc:description xml:lang="en">In the present work, the opinion of the Supreme Court of the United States (13 june 2013) on patentability of human genes is analyzed (No. 12-398, Association for Molecular Pathology et ál. v. Myriad Genetics, Inc. et ál) in relation to the BRCA1 and BRCA2 genes which predispose women to breast cancer and ovarian cancer. The legal status in the European Union and in Spain is also analyzed.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 Jan-Jun </dc:date>
<dc:title xml:lang="es">Patentes de genes humanos ¿sí o no?: reflexiones en torno a la sentencia del Tribunal Supremo de los Estados Unidos.</dc:title>
<dc:title xml:lang="en">[Human genes patents: yes or no? Reflections on the ruling of the Supreme Court of the United States].</dc:title>
<dc:publisher>Revista de derecho y genoma humano = Law and the human genome review</dc:publisher>
</metadata>
</record>
</pubmed-document>
